Credit Suisse’s Evogene EVGN Stock Holding History

Credit Suisse’s Portfolio EVGN Stock Details EVGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-5,728	Closed	-$94K	–	3838
2021 Q4	$94K	Buy	+5,728	New	+$130K	﹤0.01%	4387
2014 Q4	–	Sell	-10,042	Closed	-$1.32M	–	4616
2014 Q3	$1.32M	Buy	10,042 +32	+0.3%	+$4.42K	﹤0.01%	2810
2014 Q2	$1.64M	Sell	10,010 -394	-4%	-$67.8K	﹤0.01%	2887
2014 Q1	$1.98M	Buy	+10,404	New	+$1.97M	﹤0.01%	2509

Other funds holding EVGN

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

EVC

Eidelman Virant Capital Saint Louis, Missouri $136M AUM 15.11% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

VIA

Vident Investment Advisory Alpharetta, Georgia $2.9B AUM 24.67% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Credit Suisse's EVGN Position: Q1 2022 in Review

Credit Suisse sold out of Evogene (EVGN) in Q1 2022, closing a stake of 5,728 shares — an estimated $94K sold.

Credit Suisse first reported a position in EVGN in Q1 2014 and held it in 4 quarters. The position peaked at $1.98M in Q1 2014. 38 funds tracked by Wall St. Rank hold EVGN as of Q1 2022.

Credit Suisse reported no remaining Evogene position as of Q1 2022 after selling out during the quarter.
Credit Suisse sold 5,728 Evogene shares in Q1 2022, an estimated $94K.
Credit Suisse first reported a position in Evogene in Q1 2014 and held it in 4 quarters.
Credit Suisse's Evogene position peaked at $1.98M in Q1 2014.
38 funds tracked by Wall St. Rank held Evogene as of Q1 2022.

Based on Credit Suisse's 13F filing for Q1 2022, filed 16 May 2022.